Truist Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $50

Benzinga · 2d ago
Truist Securities analyst Joon Lee maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $36 to $50.